Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 1 Cumulative major adverse cardiac events (MACE) rate (death, nonfatal myocardial infarction, or re-intervention) during the first month for control patients (bare stent) and patients treated with sirolimus-eluting stents (SES). Note that >50% of events occurred during the first week in both groups.
|
